A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS

Neurology

Volumn 73, Issue 1, 2009, Pages 16-24

  Wills, A M ^a,s   Cronin, S ^b   Slowik, A ^c   Kasperaviciute, D ^d   Van Es, M A ^e   Morahan, J M ^f,g   Valdmanis, P N ^h,i   Meininger, V ^j   Melki, J ^k   Shaw, C E ^l   Rouleau, G A ^h,i   Fisher, E M C ^d   Shaw, P J ^m   Morrison, K E ⁿ   Pamphlett, R ^f   Van Den Berg, L H ^e   Figlewicz, D A ^o,p   Andersen, P M ^q   Al Chalabi, A ^l   Hardiman, O ^b,r   Purcell, S ^a   Landers, J E ^a   Brown Jr , R H ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF SYDNEY   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF MONTREAL   (Canada)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^l KING'S COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁿ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^o UNIVERSITY OF MICHIGAN   (United States)

^p ALS Society of Canada   (Canada)

^q UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^r TRINITY COLLEGE DUBLIN   (Ireland)

^s CNY 114 3125 ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE LOCUS; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; HOMOZYGOTE; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 68249141410     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a18674     Document Type: Article

References (37)

1. Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2007;16:R233-242.
2. Simpson CL, Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta 2006;1762:973-985.
3. Slowik A, Tomik B, Wolkow PP, et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 2006;67:766-770.
4. Saeed M, Siddique N, Hung WY, et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 2006;67:771-776.
5. Morahan JM, Yu B, Trent RJ, Pamphlett R. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 2007;28:532-540.
6. Cronin S, Greenway MJ, Prehn JH, Hardiman O. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78:984-986.
7. Valdmanis P, Kabashi E, Dyck A, et al. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec and Sweden. Neurology 2008;71:514-520.
8. Landers JE, Shi L, Cho TJ, et al. A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler 2008:1-9.
9. Kasperaviciute D, Weale ME, Shianna KV, et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 2007;130:2292-2301.
10. Schymick JC, Scholz SW, Fung HC, et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007;6:322-328.
11. Dunckley T, Huentelman MJ, Craig DW, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 2007;357:775-788.
12. van Es MA, Van Vught PW, Blauw HM, et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 2007;6:869-877.
13. van Es MA, van Vught PW, Blauw HM, et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 2008;40:29-31.
14. Aldridge WN. Serum esterases: II: An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem J 1953;53:117-124.
15. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 1989;180:242-247.
16. Muddasir Qureshi M, Hayden D, Urbinelli L, et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler 2006;7:173-182.
17. Rosati G, Pinna L, Granieri E, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977;55:231-244.
18. Holloway SM, Emery AE. The epidemiology of motor neuron disease in Scotland. Muscle Nerve 1982;5:131-133.
19. McGuire V, Longstreth WT Jr, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
20. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001;68:1428-1436.
21. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996;14:334-336.
22. Mackness B, Durrington PN, Mackness MI. The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 2002;13:357-362.
23. Landers J, Melki J, Meininger V, et al. Genetic variants in kinesin-associated protein gene KIFAP3 modify survival in sporadic amyotrophic lateral sclerosis. Submitted 2009.
24. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
25. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
26. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
29. Xing C, Schumacher FR, Conti DV, Witte JS. Comparison of missing data approaches in linkage analysis. BMC Genet 2003;4(suppl 1):S44.
30. Purcell S. Whole genome association analysis toolset. In: PLINK v1.00. Available at: http://pngu.mgh.harvard.edu/purcell/plink/. Accessed May 2008.
31. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
32. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
33. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
34. Barrett J, Fry B, Maller J, Daly MJ. Haploview 4.0. Available at: http://www.broad.mit.edu/mpg/haploview/. Accessed May 2008.
35. Cronin S, Berger S, Ding J, et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 2008;17:768-774.
36. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
37. Erlich PM, Lunetta KL, Cupples LA, et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet 2006;15:77-85.